Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiential and Structural Determinants of Communicable Disease Reporting Among Health Care Providers in Alameda County, California.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O<sup>6</sup>-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.

Cancer·2026
Same author

TDLAS-based distributed monitoring method for multi-component gas leakage in crude oil storage tanks.

Optics express·2026
Same author

Global trends in robotic-assisted laparoscopic surgery (RALS): a bibliometric analysis (2000-2024).

Updates in surgery·2026
Same author

Activation of PPARγ and CPT1A Mediates the Hepatoprotective Effect of Ginsenoside CK against NAFLD in Rats.

Biological procedures online·2026
Same author

Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems.

Journal of acquired immune deficiency syndromes (1999)·2026

Related Experiment Video

Updated: May 5, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.0K

Disseminated BCGosis After Intravesical BCG Installation for Bladder Cancer.

Tyler Martinson1, C Bradley Hare2, Andrea Kirmaier3

  • 1Department of Internal Medicine, Kaiser Permanente, San Francisco, California, USA.

Case Reports in Infectious Diseases
|October 6, 2025
PubMed
Summary

BCGosis is a rare complication after Bacillus Calmette-Guérin (BCG) bladder cancer treatment. Early recognition and antimycobacterial therapy are crucial for managing this condition.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Urology

Background:

  • Intravesical Bacillus Calmette-Guérin (BCG) is a standard treatment for bladder cancer.
  • BCGosis, a rare complication, can arise after BCG therapy.
Keywords:
BCG immunotherapy complicationsBacillus Calmette–Guérinbladder cancerdisseminated BCGosismycobacterial infection

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.0K

Related Experiment Videos

Last Updated: May 5, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.0K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.0K
  • Understanding BCGosis is essential for patient management.